1. Home
  2. VVX vs SUPN Comparison

VVX vs SUPN Comparison

Compare VVX & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo V2X Inc.

VVX

V2X Inc.

HOLD

Current Price

$55.55

Market Cap

1.7B

ML Signal

HOLD

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$51.77

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VVX
SUPN
Founded
2014
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
2.6B
IPO Year
2014
2012

Fundamental Metrics

Financial Performance
Metric
VVX
SUPN
Price
$55.55
$51.77
Analyst Decision
Buy
Strong Buy
Analyst Count
10
5
Target Price
$62.60
$61.60
AVG Volume (30 Days)
366.6K
707.0K
Earning Date
11-03-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
791.53
N/A
EPS
2.51
N/A
Revenue
$4,419,142,000.00
$681,539,000.00
Revenue This Year
$4.42
$8.32
Revenue Next Year
$5.45
$23.36
P/E Ratio
$22.01
N/A
Revenue Growth
5.10
4.54
52 Week Low
$41.08
$29.16
52 Week High
$63.74
$57.65

Technical Indicators

Market Signals
Indicator
VVX
SUPN
Relative Strength Index (RSI) 51.93 69.13
Support Level $52.21 $47.98
Resistance Level $56.49 $52.11
Average True Range (ATR) 1.96 1.53
MACD 0.08 0.72
Stochastic Oscillator 54.71 93.20

Price Performance

Historical Comparison
VVX
SUPN

About VVX V2X Inc.

V2X Inc is a U.S.-based company that provides services to the U.S. government. It operates as one segment and offers facility and logistics services and information technology mission support and engineering and digital integration services. The information technology and network communications capabilities consist of communications systems operations and maintenance, management and service support, systems installation and activation, system-of-systems engineering and software development, and mission support for the department of defense. The facility and logistics service include airfield management, ammunition management, civil engineering, communications, emergency services, life support activities, public works, security, transportation operations, and others.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

Share on Social Networks: